Renal tumors: diagnostic and prognostic biomarkers - Wikidata - awgldk - TriplyDB

Renal tumors: diagnostic and prognostic biomarkers

Renal tumors: diagnostic and prognostic biomarkers

http://www.wikidata.org/entity/Q26860500

about

Tetravalent antibody-scTRAIL fusion proteins with improved properties.The prognostic value of BAP1, PBRM1, pS6, PTEN, TGase2, PD-L1, CA9, PSMA, and Ki-67 tissue markers in localized renal cell carcinoma: A retrospective study of tissue microarrays using immunohistochemistry.Aberrant methylation of PCDH8 is a potential prognostic biomarker for patients with clear cell renal cell carcinoma.PAX-8 expression in renal tumours and distant sites: a useful marker of primary and metastatic renal cell carcinoma?Piwi-interacting RNAs as novel prognostic markers in clear cell renal cell carcinomas.A systematic search strategy identifies cubilin as independent prognostic marker for renal cell carcinoma.Downregulation of HSP60 disrupts mitochondrial proteostasis to promote tumorigenesis and progression in clear cell renal cell carcinoma Molecular subtyping of metastatic renal cell carcinoma: implications for targeted therapy.Biomarkers in renal cancer.Percutaneous renal tumour biopsy.Predictive molecular biomarkers to guide clinical decision making in kidney cancer: current progress and future challenges.The Diagnosis, Treatment, and Follow-up of Renal Cell Carcinoma.Vimentin 3, the new hope, differentiating RCC versus oncocytoma Biomarkers of Renal Tumors: the Current State and Clinical Perspectives.Rapid mass spectrometric conversion of tissue biopsy samples into permanent quantitative digital proteome maps.[The WHO/ISUP grading system for renal carcinoma].Renal cell carcinoma: the search for a reliable biomarker.S100A11 is a potential prognostic marker for clear cell renal cell carcinoma.Detecting functional changes with [(18)F]FAZA in a renal cell carcinoma mouse model following sunitinib therapy.Asymptomatic Pancreatic Metastasis from Renal Cell Carcinoma Diagnosed 21 Years after Nephrectomy.MiR-99b-5p expression and response to tyrosine kinase inhibitor treatment in clear cell renal cell carcinoma patients.Histological and immunohistochemical characterization of feline renal cell carcinoma: a case series.Identification and validation of a 44-gene expression signature for the classification of renal cell carcinomas.Glycogen-Rich Clear Cell Squamous Cell Carcinoma Originating in the Oral Cavity.Prognostic Factors for Renal Cell Carcinoma Subtypes Diagnosed According to the 2016 WHO Renal Tumor Classification: a Study Involving 928 Patients.Identification of genomic copy number variations associated with specific clinical features of head and neck cancer.Succinate dehydrogenase-deficient renal cell carcinoma: detailed characterization of 11 tumors defining a unique subtype of renal cell carcinoma.A miRNA-based classification of renal cell carcinoma subtypes by PCR and in situ hybridization.Evaluation of PAX8 Expression and Its Potential Diagnostic and Prognostic Value in Renal and Extra-Renal Ewing Sarcomas/PNETs.Pax8, Napsin A, and CD10 as Immunohistochemical Markers of Canine Renal Cell Carcinoma.Expression and clinicopathological correlations of retinoid acid receptor responder protein 1 in renal cell carcinomas.Histone H3 Lysine 4 Trimethylation, Lysine 27 Trimethylation, and Lysine 27 Acetylation Contribute to the Transcriptional Repression of Solute Carrier Family 47 Member 2 in Renal Cell Carcinoma.The ISUP system of staging, grading and classification of renal cell neoplasia.Unsuspected Xp11 Translocation Renal Neoplasm Associated With Contralateral Clear Cell Carcinoma.[Vancouver classification of renal tumors: Recommendations of the 2012 consensus conference of the International Society of Urological Pathology (ISUP)].Renal cell carcinoma in a cat with polycystic kidney disease undergoing renal transplantation.

P2860

Q33619046-200B61A1-99BC-49E9-9C09-BBF383098E60 Q33842185-28C7ABD8-C696-4C26-9B4D-60A96F1BD01F Q34609542-CDC376D0-FD08-42A2-A923-5C616C7F5450 Q35598471-B85A3A93-DD35-44B7-8624-326B66C95EB7 Q35741847-918CC149-B221-4AB7-A5A4-D2BACBD54F07 Q36239773-551EAC90-249C-4BF5-98CB-466047DDD20B Q37437672-C2649BCC-F752-411F-9097-B34A77B243C9 Q37623118-B3A6C4E6-0D2C-41D1-9953-1267E1CD7058 Q38184386-ABA248BD-F9D1-4182-9748-74961CB3CA49 Q38231652-BD204171-CD28-462A-ACBE-95A303573C0D Q38402997-8DEAE4DA-8133-4C8F-A405-EF51D282136C Q38961755-9EF1EE85-C618-4BB5-8949-4FE68AA70A90 Q39010437-A4689E29-E2D1-4760-9420-B34B9A36842C Q39097822-A127AF8C-4155-4007-8F2E-DB3A2D36A4F3 Q39404529-63BBE086-864D-41B3-8E27-A23566DCB7AF Q40714570-DF246E65-C311-4108-9531-AE4336CAB9B5 Q41197945-9B22CE5C-65D1-47C9-AB66-620812A554D8 Q41211662-0FA301DB-247B-4016-839F-F7265FA3E531 Q41505826-8E523033-911A-4D6B-A5DF-886D38CF3624 Q41688145-AE1F0DDF-D042-4506-B65E-A8B9C7DA43D8 Q42317002-A79C780B-0480-4790-B0FF-8D3A30742FC4 Q42428624-BAB0C1CF-B954-4355-8424-6255FDE0A02F Q47104226-EC9E858D-D18B-4C5D-9B6B-1733CE6AB880 Q47816274-0DAFA69C-23F6-46CD-A6EE-22EB14752F89 Q48109890-D27F3434-982E-4973-92B1-54A5414A1F0E Q48162253-4E0DADEA-DFE1-4B28-BB1A-F8AAB101F81F Q48289707-306EA7DB-7676-4497-A971-FE2963573D2A Q49425132-8F4DA5C5-1335-43B4-BF33-AE804F39A213 Q50210216-1957A5D4-0E74-4B41-B7CA-A424C2489D59 Q51084111-DC18C223-5507-485A-ADE4-2DA5ECC83738 Q51684494-E7F0AB75-1F85-42C1-A118-1CDAA8B9B3DE Q52822308-C31DF6DB-E62B-44FD-BFE7-DB0895582CBC Q53097603-CD202B36-A0FE-4580-86E4-E9103EF67007 Q53220937-B47C9265-B18F-49D0-B09F-9D9A87DA7B49 Q55070224-4C3E1C61-FD90-4BEB-BBF1-99CE796679A5 Q55117295-3684B71D-2B7D-4F72-B6AF-BF2281EA36DE

P2860

Renal tumors: diagnostic and prognostic biomarkers

http://www.wikidata.org/entity/Q26860500

description

2013 nî lūn-bûn

@nan

2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Renal tumors: diagnostic and prognostic biomarkers

@ast

Renal tumors: diagnostic and prognostic biomarkers

@en

Renal tumors: diagnostic and prognostic biomarkers

@nl

type

label

Renal tumors: diagnostic and prognostic biomarkers

@ast

Renal tumors: diagnostic and prognostic biomarkers

@en

Renal tumors: diagnostic and prognostic biomarkers

@nl

prefLabel

Renal tumors: diagnostic and prognostic biomarkers

@ast

Renal tumors: diagnostic and prognostic biomarkers

@en

Renal tumors: diagnostic and prognostic biomarkers

@nl

P1433

Q26860500-04531CC5-2957-4F7D-818C-3D8785DFA868

P1476

Q26860500-FE1F11F0-DCEC-43DB-8D14-AB8880CE1B1D

P2093

Q26860500-28F19376-BEAD-49A8-BAA3-AA29FEAD97C2

Q26860500-37C6536B-3CC6-4CA9-A247-2F8E5334B94A

Q26860500-3E27D2AC-EE08-439B-84A4-DD8AA53CA39F

Q26860500-575CE6BE-7D72-49D5-B363-B49BD614FA8C

Q26860500-5BB44BFF-440D-49BE-AD24-7428C0FA01C9

Q26860500-6B1BBE78-9F9C-4FBB-884E-7044EA966CEB

Q26860500-74AA8ED1-4EB7-4AF7-86A5-3144402C68BC

Q26860500-A659EEA1-2BDE-4083-8997-F78237972754

Q26860500-B9A32CB6-C81D-4DC1-B7B0-2024F84DC6CA

Q26860500-BF11B257-5E2A-4C0B-A393-DEBFD9100521

P2860

Q26860500-215837D1-4F33-4681-B6D3-0FBBAB6ACCC1

Q26860500-2A2FB4D5-2EED-4EB1-A1F7-83E17EC93778

Q26860500-2ABD385B-087E-44C9-A0D0-18628A58F6A7

Q26860500-2C07C97F-F7CB-4CFF-ACEF-5EBA47A7D938

Q26860500-2C43D321-E239-4807-92D8-A18B814C7FC8

Q26860500-2EF7712B-933B-4FC7-87C9-D1FEFD8A26FD

Q26860500-32FD5831-5E6D-4472-BD0A-187BDD72F6D4

Q26860500-36FD14D4-88B0-4C2D-839C-7CC1BE259798

Q26860500-3A4E4242-1F58-461B-ABCF-58A332506515

Q26860500-3B715C97-4266-4EDC-A686-C37C6FB8F57F

P304

Q26860500-4CAD544B-568E-46F0-B9CE-A19C677293F0

P31

Q26860500-E1CE635C-45BA-4C57-9705-342BA1AFB290

P3181

Q26860500-575785EC-26E4-4C24-A17A-7136BF8EAEE3

P356

Q26860500-CB6721B1-5E46-4FAB-B30C-4A863D7FDF75

P407

Q26860500-0F929738-16E1-4BD1-901C-019467FD1AD3

P433

Q26860500-2244D5AC-F26B-4E18-93CA-4FD05EAFA1F9

P478

Q26860500-18280FED-7389-423D-8038-CB5122829A6B

P50

Q26860500-926F3930-DC2D-43AA-B0B2-EC4A1937B771

Q26860500-D077A23E-33EE-453A-96B8-2761FB2F0C7B

Q26860500-D423922C-3456-4A16-8C08-DAF82A0D9A95

P577

Q26860500-F0D53366-DF26-4510-8286-645FBAB20B35

P698

Q26860500-49B52293-763B-42F3-AD72-DD99D9B68B21

P921

Q26860500-A2BE746C-B386-4918-9FA8-74FD7D56FF33

Q26860500-f18f88eb-b21d-411f-ad8b-bb53b95f6527

P932

Q26860500-BDFE2EA2-BEDB-48AC-AE8F-D6A8A9585827

P3181

P356

PAS.0B013E318299F12E

P1433

The American Journal of Surgical Pathology

P1476

Renal tumors: diagnostic and prognostic biomarkers

@en

P2093

Brett Delahunt

http://www.w3.org/2001/XMLSchema#string

David J. Grignon

http://www.w3.org/2001/XMLSchema#string

George Netto

http://www.w3.org/2001/XMLSchema#string

Holger Moch

http://www.w3.org/2001/XMLSchema#string

John R. Srigley

http://www.w3.org/2001/XMLSchema#string

Liang Cheng

http://www.w3.org/2001/XMLSchema#string

Maria J. Merino

http://www.w3.org/2001/XMLSchema#string

Puay Hoon Tan

http://www.w3.org/2001/XMLSchema#string

Steven S. Shen

http://www.w3.org/2001/XMLSchema#string

Victor E. Reuter

http://www.w3.org/2001/XMLSchema#string

P2860

Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma

Prevalence of von Hippel-Lindau gene mutations in sporadic renal cell carcinoma: results from The Netherlands cohort study

Low CAIX expression and absence of VHL gene mutation are associated with tumor aggressiveness and poor survival of clear cell renal cell carcinoma

Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy

Immunoreactivity of CD10 and inhibin alpha in differentiating hemangioblastoma of central nervous system from metastatic clear cell renal cell carcinoma

Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial

KIT and RCC are useful in distinguishing chromophobe renal cell carcinoma from the granular variant of clear cell renal cell carcinoma.

Breast cancer metastatic to the kidney.

Immunohistochemical distinction of primary adrenal cortical lesions from metastatic clear cell renal cell carcinoma: a study of 248 cases

Clear-cell papillary renal cell carcinoma: molecular and immunohistochemical analysis with emphasis on the von Hippel-Lindau gene and hypoxia-inducible factor pathway-related proteins.

P304

1518-31

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4816491

http://www.w3.org/2001/XMLSchema#string

P356

10.1097/PAS.0B013E318299F12E

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

37

http://www.w3.org/2001/XMLSchema#string

P50

Nathalie Rioux-Leclercq

Rodolfo Montironi

P577

2013-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24025522

http://www.w3.org/2001/XMLSchema#string

P921

P932

4714713

http://www.w3.org/2001/XMLSchema#string